PM
Therapeutic Areas
Velorum Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Velorum-PPX | Erythropoietic Protoporphyria (EPP) / X‑linked Protoporphyria (XLP) | Preclinical |
| Velorum-HemeSequester | Cancer / Kidney injury / Hemolysis | Preclinical |
Leadership Team at Velorum Therapeutics
PM
Parsa Modareszadeh
Co‑founder & President
RS
Richard Showalter
VP of Research & Development
HJ
Harri Järveläinen
Preclinical and Translational Sciences
LR
Lucas Rodriguez
Business Development
DH
David Hitt
Legal & Intellectual Property